H Matsushima Selected Research

H Matsushima Research Topics

Disease

3	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2020 - 01/2001
3	Cataract (Cataracts) 07/2012 - 05/2000
2	Autoimmune Hepatitis 11/2001 - 01/2000
2	Chronic Hepatitis C 11/2001 - 01/2000
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2001 - 05/2000
1	Autoimmune Diseases (Autoimmune Disease) 04/2020
1	Polymyositis 04/2020
1	Pulmonary Alveolar Proteinosis 04/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 04/2020
1	Ileus 12/2016
1	Rupture 07/2012
1	Wounds and Injuries (Trauma) 07/2012
1	Thrombocytopenia (Thrombopenia) 03/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2004
1	Tuberculosis (Tuberculoses) 09/2004
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 06/2004
1	Basal Cell Carcinoma (Rodent Ulcer) 04/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2003
1	Oliguria 09/2001
1	Acute Kidney Injury (Acute Renal Failure) 09/2001
1	Respiratory Insufficiency (Respiratory Failure) 09/2001
1	Lung Neoplasms (Lung Cancer) 08/2001
1	Kidney Neoplasms (Kidney Cancer) 08/2001
1	IGA Glomerulonephritis (IGA Nephropathy) 08/2001
1	Ocular Hypertension (Glaucoma, Suspect) 07/2001
1	Glaucoma 07/2001
1	Rheumatoid Arthritis 01/2001
1	Cysts 05/2000
1	Dehydration (Water Stress) 04/2000
1	Carcinoma (Carcinomatosis) 03/2000
1	Prostatic Neoplasms (Prostate Cancer) 03/2000
1	Neoplasms (Cancer) 03/2000
1	Chronic Hepatitis B 01/2000

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2000
4	AutoantibodiesIBA 04/2020 - 01/2000
2	Pharmaceutical PreparationsIBA 12/2016 - 01/2001
2	Indicators and Reagents (Reagents)IBA 09/2004 - 03/2000
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2001 - 01/2000
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2001 - 01/2000
2	AutoantigensIBA 11/2001 - 01/2000
2	SteroidsIBA 08/2001 - 07/2001
2	Selenious Acid (Selenite)IBA 06/2000 - 05/2000
2	Cytoskeletal ProteinsIBA 06/2000 - 05/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2020
1	Surface-Active Agents (Surfactants)IBA 04/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2020
1	AnkyrinsIBA 12/2016
1	Capsules (Microcapsules)IBA 07/2012
1	Heparin (Liquaemin)FDA LinkGeneric 03/2010
1	Parathyroid Hormone (Parathormone)IBA 09/2004
1	Calcitriol (Calcijex)FDA LinkGeneric 09/2004
1	CalciumIBA 09/2004
1	Vitamin D FDA LinkGeneric 09/2004
1	AntibodiesIBA 06/2004
1	CateninsIBA 04/2003
1	afadinIBA 04/2003
1	NectinsIBA 04/2003
1	Cadherins (E-Cadherin)IBA 04/2003
1	Peptides (Polypeptides)IBA 11/2001
1	CreatinineIBA 09/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2001
1	Dextrans (Dextran)FDA Link 09/2001
1	Interferon-alpha (Interferon Alfa)IBA 08/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2001
1	InterferonsIBA 08/2001
1	Immunoglobulin A (IgA)IBA 08/2001
1	Messenger RNA (mRNA)IBA 08/2001
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2001
1	Acetates (Acetic Acid Esters)FDA Link 07/2001
1	GlucocorticoidsIBA 07/2001
1	trabecular meshwork-induced glucocorticoid response proteinIBA 07/2001
1	bucillamine (SA 96)IBA 01/2001
1	VimentinIBA 06/2000
1	SpectrinIBA 06/2000
1	SeleniumIBA 05/2000
1	Crystallins (Crystallin)IBA 05/2000
1	Colloids (Colloid)IBA 05/2000
1	polyacrylamideIBA 05/2000
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 05/2000
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 04/2000
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 04/2000
1	EnzymesIBA 04/2000
1	beta-AmylaseIBA 04/2000
1	Dinoprostone (PGE2)FDA Link 03/2000
1	AgarIBA 03/2000
1	PapaverineIBA 03/2000
1	N 30IBA 01/2000
1	Recombinant ProteinsIBA 01/2000
1	Complementary DNA (cDNA)IBA 01/2000
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2000
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2000
1	Cytochrome P-450 CYP3AIBA 01/2000

Therapy/Procedure

2	Therapeutics 08/2001 - 03/2000
1	Traditional Medicine (Folk Remedies) 12/2016
1	Capsulorhexis 07/2012
1	Phacoemulsification 07/2012
1	Renal Dialysis (Hemodialysis) 03/2010
1	Aftercare (After-Treatment) 09/2004
1	Nephrectomy 05/2000